Medicinova Inc SEC filings MNOV
Medicinova Inc has 879 filings in SEC EDGAR's recent list, going back to Apr 8, 2003. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 28, 2026 (material agreement). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Material agreement
|
Sep 28, 2026 | Sep 23, 2026 |
| 8-K |
Current report
Agreement ended
|
Sep 2, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 19, 2026 | Aug 17, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 24, 2026 | Jun 23, 2026 |
| 10-Q | Quarterly report | May 14, 2026 | Mar 31, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Jun 23, 2026 |
| PRER14A | Filing | Apr 20, 2026 | — |
| PRE 14A | Preliminary proxy statement | Apr 17, 2026 | Jun 23, 2026 |
| 10-K | Annual report | Mar 10, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Feb 20, 2026 | Feb 20, 2026 |
| 424B5 | Prospectus supplement | Dec 30, 2025 | — |
| 8-K |
Current report
Material agreement
|
Dec 30, 2025 | Dec 29, 2025 |
| EFFECT | Filing | Dec 11, 2025 | — |
| CORRESP | Letter to the SEC | Dec 9, 2025 | — |
| S-3 | Shelf registration | Dec 5, 2025 | — |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| EFFECT | Filing | Sep 30, 2025 | — |
| CORRESP | Letter to the SEC | Sep 26, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 26, 2025 | — |
| S-1 | Registration statement | Aug 22, 2025 | — |
| 10-Q | Quarterly report | Aug 14, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement
|
Aug 1, 2025 | Jul 30, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 18, 2025 | Jun 17, 2025 |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| ARS | Annual report to shareholders | Apr 28, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 28, 2025 | — |
| DEF 14A | Proxy statement | Apr 28, 2025 | Jun 17, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 11, 2025 | Mar 11, 2025 |
| 10-K | Annual report | Feb 19, 2025 | Dec 31, 2024 |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2024 | Jun 11, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 1, 2024 | Mar 26, 2024 |
| 10-K | Annual report | Feb 15, 2024 | Dec 31, 2023 |
| S-8 POS | Filing | Jan 19, 2024 | — |
| S-8 POS | Filing | Jan 19, 2024 | — |
| S-8 POS | Filing | Jan 19, 2024 | — |
| S-8 POS | Filing | Jan 19, 2024 | — |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 10-Q | Quarterly report | Aug 9, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Officer or director change
|
Aug 7, 2023 | Aug 4, 2023 |
| 8-K |
Current report
Listing notice
|
Jun 22, 2023 | Jun 15, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2023 | Jun 13, 2023 |
| 10-Q | Quarterly report | May 11, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Officer or director change
|
Apr 26, 2023 | Apr 20, 2023 |
| ARS | Annual report to shareholders | Apr 26, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | Apr 26, 2023 | — |
| DEF 14A | Proxy statement | Apr 26, 2023 | Jun 13, 2023 |
| 10-K/A | Amended annual report | Mar 28, 2023 | Dec 31, 2022 |
| 10-K | Annual report | Feb 16, 2023 | Dec 31, 2022 |
| 10-Q | Quarterly report | Nov 10, 2022 | Sep 30, 2022 |
| 424B5 | Prospectus supplement | Sep 30, 2022 | — |
| EFFECT | Filing | Sep 6, 2022 | — |
| CORRESP | Letter to the SEC | Sep 1, 2022 | — |
| UPLOAD | Letter from the SEC | Aug 31, 2022 | — |
| S-3 | Shelf registration | Aug 26, 2022 | — |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| 8-K |
Current report
Officer or director change
|
Jun 21, 2022 | Jun 16, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2022 | Jun 14, 2022 |
| S-8 | Employee stock plan registration | May 13, 2022 | — |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| DEFA14A | Additional proxy material | Apr 26, 2022 | — |
| DEF 14A | Proxy statement | Apr 26, 2022 | Jun 14, 2022 |
| 8-K |
Current report
Other events
|
Apr 5, 2022 | Apr 4, 2022 |
| 10-K | Annual report | Feb 16, 2022 | Dec 31, 2021 |
| 10-Q | Quarterly report | Nov 12, 2021 | Sep 30, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Officer or director change
|
Aug 2, 2021 | Jul 31, 2021 |
| 8-K |
Current report
Material agreement
|
Jul 23, 2021 | Jul 20, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2021 | Jun 16, 2021 |
| 8-K |
Current report
Other events
|
May 18, 2021 | May 17, 2021 |
| 10-Q | Quarterly report | May 13, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Other events
|
May 5, 2021 | May 5, 2021 |
| DEFA14A | Additional proxy material | Apr 27, 2021 | — |
| DEF 14A | Proxy statement | Apr 27, 2021 | Jun 16, 2021 |
| 10-K | Annual report | Feb 19, 2021 | Dec 31, 2020 |
| 424B3 | Prospectus | Feb 12, 2021 | — |
| EFFECT | Filing | Feb 10, 2021 | — |
| CORRESP | Letter to the SEC | Feb 8, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 5, 2021 | — |
| 8-K |
Current report
Unregistered share sale, Other events
|
Feb 1, 2021 | Jan 29, 2021 |
| S-3 | Shelf registration | Jan 29, 2021 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Other events
|
Jan 12, 2021 | Jan 11, 2021 |
| 10-Q | Quarterly report | Oct 26, 2020 | Sep 30, 2020 |
| 8-K |
Current report
Officer or director change
|
Oct 21, 2020 | Oct 19, 2020 |
| 10-Q | Quarterly report | Jul 28, 2020 | Jun 30, 2020 |
| 8-K |
Current report
Officer or director change
|
Jun 22, 2020 | Jun 19, 2020 |
| 8-K |
Current report
Shareholder vote results
|
Jun 17, 2020 | Jun 16, 2020 |
| DEFA14A | Additional proxy material | Apr 28, 2020 | — |
| DEF 14A | Proxy statement | Apr 27, 2020 | Jun 16, 2020 |
| 10-Q | Quarterly report | Apr 23, 2020 | Mar 31, 2020 |
| 8-K |
Current report
Officer or director change
|
Apr 23, 2020 | Apr 22, 2020 |
| 8-K |
Current report
Officer or director change
|
Apr 16, 2020 | Apr 15, 2020 |
| 10-K | Annual report | Feb 13, 2020 | Dec 31, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 28, 2019 | Oct 28, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 25, 2019 | Oct 25, 2019 |
| 10-Q | Quarterly report | Oct 24, 2019 | Sep 30, 2019 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Aug 23, 2019 | Aug 23, 2019 |
| 424B5 | Prospectus supplement | Aug 23, 2019 | — |
| EFFECT | Filing | Aug 22, 2019 | — |
| CORRESP | Letter to the SEC | Aug 20, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 14, 2019 | — |
| S-3 | Shelf registration | Aug 9, 2019 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 26, 2019 | Jul 26, 2019 |
| 10-Q | Quarterly report | Jul 25, 2019 | Jun 30, 2019 |
| 8-K |
Current report
Officer or director change
|
Jul 25, 2019 | Jul 24, 2019 |
| S-8 | Employee stock plan registration | Jun 21, 2019 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2019 | Jun 10, 2019 |
| DEFA14A | Additional proxy material | May 1, 2019 | — |
| DEF 14A | Proxy statement | Apr 26, 2019 | Jun 10, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 26, 2019 | Apr 26, 2019 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Apr 25, 2019 | Apr 23, 2019 |
| 10-Q | Quarterly report | Apr 25, 2019 | Mar 31, 2019 |
| 8-K |
Current report
Officer or director change
|
Mar 12, 2019 | Mar 6, 2019 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 14, 2019 | Feb 14, 2019 |
| 10-K | Annual report | Feb 13, 2019 | Dec 31, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 26, 2018 | Oct 26, 2018 |
| 10-Q | Quarterly report | Oct 25, 2018 | Sep 30, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 24, 2018 | Jul 24, 2018 |
| 10-Q | Quarterly report | Jul 23, 2018 | Jun 30, 2018 |
| 8-K |
Current report
Shareholder vote results
|
Jun 11, 2018 | Jun 7, 2018 |
| 8-K |
Current report
Officer or director change
|
Jun 5, 2018 | Jun 1, 2018 |
| DEFA14A | Additional proxy material | May 9, 2018 | — |
| DEFA14A | Additional proxy material | Apr 26, 2018 | — |
| DEF 14A | Proxy statement | Apr 26, 2018 | Jun 7, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 26, 2018 | Apr 26, 2018 |
| 10-Q | Quarterly report | Apr 25, 2018 | Mar 31, 2018 |
| 8-K |
Current report
Other events
|
Feb 21, 2018 | Feb 21, 2018 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 14, 2018 | Feb 14, 2018 |
| 10-K | Annual report | Feb 13, 2018 | Dec 31, 2017 |
| 8-K |
Current report
Material agreement, Other events
|
Feb 8, 2018 | Feb 7, 2018 |
| 424B5 | Prospectus supplement | Feb 8, 2018 | — |
| 424B5 | Prospectus supplement | Feb 7, 2018 | — |
| 8-K |
Current report
Officer or director change
|
Nov 13, 2017 | Nov 9, 2017 |
| UPLOAD | Letter from the SEC | Nov 6, 2017 | — |
| 8-K |
Current report
Other events
|
Oct 30, 2017 | Oct 30, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 24, 2017 | Oct 24, 2017 |
| 10-Q | Quarterly report | Oct 23, 2017 | Sep 30, 2017 |
| EFFECT | Filing | Oct 2, 2017 | — |
| CORRESP | Letter to the SEC | Sep 27, 2017 | — |
| S-3 | Shelf registration | Sep 22, 2017 | — |
| 8-K |
Current report
Material agreement
|
Sep 7, 2017 | Aug 31, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 27, 2017 | Jul 27, 2017 |
| 10-Q | Quarterly report | Jul 26, 2017 | Jun 30, 2017 |
| S-8 | Employee stock plan registration | Jul 26, 2017 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 12, 2017 | Jun 8, 2017 |
| DEF 14A | Proxy statement | Apr 27, 2017 | Jun 8, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 27, 2017 | Apr 27, 2017 |
| 10-Q | Quarterly report | Apr 26, 2017 | Mar 31, 2017 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 15, 2017 | Feb 15, 2017 |
| 10-K | Annual report | Feb 14, 2017 | Dec 31, 2016 |
| EFFECT | Filing | Dec 9, 2016 | — |
| 424B3 | Prospectus | Dec 9, 2016 | — |
| S-3 | Shelf registration | Nov 29, 2016 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 10, 2016 | Nov 10, 2016 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 26, 2016 | Oct 26, 2016 |
| 10-Q | Quarterly report | Oct 25, 2016 | Sep 30, 2016 |
| 424B5 | Prospectus supplement | Sep 16, 2016 | — |
| 8-K |
Current report
Material agreement
|
Sep 16, 2016 | Sep 16, 2016 |
| EFFECT | Filing | Aug 29, 2016 | — |
| CORRESP | Letter to the SEC | Aug 25, 2016 | — |
| S-3/A | Filing | Aug 24, 2016 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 27, 2016 | Jul 27, 2016 |
| 10-Q | Quarterly report | Jul 26, 2016 | Jun 30, 2016 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2016 | Jun 9, 2016 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 28, 2016 | Apr 28, 2016 |
| DEF 14A | Proxy statement | Apr 27, 2016 | Jun 9, 2016 |
| 10-Q | Quarterly report | Apr 27, 2016 | Mar 31, 2016 |
| 8-K |
Current report
Material agreement, Agreement ended, Officer or director change
|
Mar 31, 2016 | Mar 31, 2016 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 26, 2016 | Feb 26, 2016 |
| 10-K | Annual report | Feb 25, 2016 | Dec 31, 2015 |
| S-3/A | Filing | Dec 18, 2015 | — |
| UPLOAD | Letter from the SEC | Dec 14, 2015 | — |
| S-3 | Shelf registration | Dec 1, 2015 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 30, 2015 | Oct 30, 2015 |
| 10-Q | Quarterly report | Oct 29, 2015 | Sep 30, 2015 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 25, 2015 | Sep 25, 2015 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 1, 2015 | Sep 1, 2015 |
| 8-K |
Current report
Other events
|
Aug 25, 2015 | Aug 24, 2015 |
| 424B5 | Prospectus supplement | Aug 19, 2015 | — |
| 8-K |
Current report
Material agreement
|
Aug 19, 2015 | Aug 18, 2015 |
| 424B3 | Prospectus | Aug 18, 2015 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 31, 2015 | Jul 31, 2015 |
| 10-Q | Quarterly report | Jul 30, 2015 | Jun 30, 2015 |
| 8-K |
Current report
Auditor change
|
Jul 2, 2015 | Jun 30, 2015 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2015 | Jun 11, 2015 |
| 424B5 | Prospectus supplement | May 22, 2015 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
May 22, 2015 | May 22, 2015 |
| 8-K |
Current report
Regulation FD disclosure
|
May 12, 2015 | May 12, 2015 |
| 10-Q | Quarterly report | May 11, 2015 | Mar 31, 2015 |
| ARS | Annual report to shareholders | May 5, 2015 | Dec 31, 2014 |
| DEF 14A | Proxy statement | Apr 29, 2015 | Jun 11, 2015 |
| 8-K |
Current report
Officer or director change
|
Apr 29, 2015 | Apr 28, 2015 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- MNOV (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- La Jolla, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1226616
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.